A new clinical trial has found that fluvoxamine — commonly used to treat depression — seems to reduce the risk of hospitalization with COVID-19. Source


And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.